Rabeprazole + Levosulpiride

Rabeprazole + Levosulpride

The combination medicine suppresses gastric acid production in the body. This is a pro-kinetic agent that is utilized in the management of functional dyspepsia on the footing of dopaminergic tracts controlling gastrointestinal motion.

Capsules can be utilized in the aid of following conditions:

Dosage:

A capsule in an empty stomach, or as recommended by Physician.

Mechanism of action:

Inhibits gastric acid secretion by specific suppression of the hydrogen-potassium adenosine triphosphatase (H+, K+-ATPase) enzyme system recovered at the secretory subsurface of parietal cells. The medicine is a sulpiride isomer, which holds its prokinetic action through a dual mechanism: 1) as a D(2) dopamine receptor opponent and 2) as a serotonin 5HT(4) receptor agonist, consulting this medicate with a cholinergic effect. It is also effective in delayed gastric evacuation and may be attendant to its activity on the gastric motor function.